PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Catalogs, Drug as Topic”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2Linked to original sources
PubMed1968

Medindex.

Explore the source record for details and available documents.

Abstracting and Indexing↗
PubMed1973

Drug data sheets.

Explore the source record for details and available documents.

Catalogs, Drug as Topic↗
PubMed1983

The Compendium of Pharmaceuticals and Specialties: a critical analysis.

The Compendium of Pharmaceuticals and Specialties (CPS) is the most widely used source of drug information in Canada, and is heavily financed by the pharmaceutical industry. A close examination of its contents comparing a computer-drawn, randomized sample of monographs from its "White Pages" to standard pharmacological reference works demonstrates certain of its characteristics: it uncritically includes many inadequate preparations; it overstates the benefits and understates the adverse qualities of many preparations; and it contains little or no information on relative indications, efficacy, or price. These characteristics serve to promote the marketing goals of the drug manufacturers and severely limit the volume's usefulness as an objective source of drug information. The role of the CPS and similar publications in the overall context of current drug company marketing strategies is discussed. Finally, suggestions for improvements are made involving the elimination of direct manufacturer financing, and the creation of an objective, independent, nonprofit publishing agency supported by professional and governmental organizations.

Canada↗
PubMed1990

AIDS drugs in research.

Explore the source record for details and available documents.

Acquired Immunodeficiency Syndrome↗
PubMed1994

Investigational drug tracking: Phases I-III and NDA submissions--Part I.

The author catalogs over 800 investigational drugs/biologicals currently in Phase I, II or III clinical trials or drugs/biologicals submitted to the FDA as new drug applications. The list assists in predicting when new drugs will be marketed. The entries include generic/chemical name, investigational drug number, synonyms, trade names, manufacturers, clinical trial status, predicted approval year, indications or drug class, whether the drug has been developed through biotechnology, and references. Entries were gleaned from medical journals, stock market analysis publications, and the Pharmaceutical Manufacturers Association's Medicines in Development Series. The list is alphabetized by the generic/chemical name or investigational drug number and cross-indexed by the trade name and synonyms. The list reflects those drugs which were not FDA approved as of April 15, 1994. Part I includes the trade name and synonym cross-indexes and the beginning of the main alphabetical listing by generic/chemical name or investigational drug number.

Catalogs, Drug as Topic↗
PubMed1979

FDA drug list: key to generic substitution.

Americans sometimes pay a premium price for brand name drugs when lower - priced products that are "therapeutically equivalent" are available. Two lanmark projects recently unveiled by the Department of Health, Education, and Welfare and the Federal Trade Commission may help consumers save money on the prescription drugs they buy.

Catalogs, Drug as Topic↗